Latest News
EU chief urges gradual easing of Covid-19 restrictions for holiday period
The president of the European Commission, Ursula von der Leyen, warned of a third wave of Covid-19 cases and urged governments to gradually lift the restrictions for the holiday period.
WHO advises against prescribing remdesivir for Covid-19
WHO advises doctors against treating Covid-19 patients with Gilead Science’s remdesivir drug (under the name Veklury) that has “no meaningful effect” on survival or need for ventilation.
Ofgem calls for increase in price cap, opens consultation
Ofgem is considering upping the price cap after the Covid-19 pandemic prompted a rise in bad debts, hitting the finances of energy suppliers.
Pfizer and BioNTech file for emergency use approval of Covid-19 vaccine with FDA
Pfizer and BioNTech have filed for Emergency Use Authorisation with America's drug regulator for their Covid-19 vaccine candidate, BNT162b2.
US pre-open: Futures point to flat open as new Covid-19 infections continue to rise
Wall Street futures were mostly flat ahead of the bell on Friday as a continued rise in new Covid-19 cases across the country continued to weigh on sentiment.
Liberum raises price target for Naked Wines
Liberum has upped its price target on Naked Wines after the Covid-19 pandemic fuelled a surge in sales.
ImmuPharma gets December date for FDA meeting
Specialist drug discovery and development company ImmuPharma updated the market on the new optimised international phase 3 trial of ‘Lupuzor’ in systemic lupus erythematosus (SLE) on Friday, reporting that the US Food & Drug Administration (FDA) has now confirmed the date of 4 December for a Type 'A' Meeting Request.
Staffline agrees sale of PeoplePlus apprenticeships division
Recruitment and training company Staffline announced on Friday that its PeoplePlus division has agreed terms to sell its apprenticeships business to Babington Business College for “a nominal fee”.
Diurnal gets European patent for 'Alkindi'
Speciality pharmaceutical company Diurnal Group announced the grant of a patent for ‘Alkindi’, or hydrocortisone granules in capsules for opening, by the European Patent Office on Friday.
Walker Greenbank enters collaboration for Scion online shop
Luxury interior design and furnishings company Walker Greenbank announced a new collaboration with internet retailer Jane Clayton and Company on Friday, to launch an online shop for its Scion brand.
Indivior appoints Ryan Preblick as CFO
Indivior has appointed Ryan Preblick as chief financial officer after he spent five months in the job on an interim basis.
ECR Minerals moves closer to drilling at Bailieston
Gold exploration and development company ECR Minerals updated the market on its activities in the Australian state of Victoria on Friday, reporting that its wholly-owned subsidiary Mercator Gold Australia (MGA) has taken delivery of its new Cortech CSD1300G diamond drill rig.
London midday: Stocks in the black after retail sales
London stocks were in the black by midday on Friday as investors digested the latest UK retail sales and borrowing data.
Europe midday: Share retain gains but keep watch on US Fed/Treasury row
European stocks remained firmer at lunch on Friday after modest gains on Wall Street as investors kept an eye on a potential spat between the US Federal Reserve and the Treasury.
Barclays starts coverage of investment platforms, likes IntegraFin
Barclays initiated coverage on AJ Bell, Quilter and IntegraFin on Friday, as it noted that UK investment platforms have traded at high multiples since their debuts in 2018, reflecting attractive structural assets under management growth.
UK retail sales continue to grow despite lockdown - BDO
Retail sales held up during the first full week of lockdown, research published on Friday showed, as consumers got their Christmas shopping underway early.
Global equities to rise 15% in 2021, Credit Suisse predicts
Global equity markets will rise by 15% by the end of 2021 bolstered by policy support and a move out of bonds, Credit Suisse analysts predicted.
Berenberg raises target price on IWG
Analysts at Berenberg upped their target price on serviced offices provider IWG from 350. 0p to 425. 0p on Friday, stating the group's "capital-light model" looked set to transform its profit and loss standing.
Unions call for frontline workers to have priority access to Covid-19 vaccine
UK unions called for key frontline workers to be given priority access for a Covid-19 vaccine once its rolled out after they were omitted from the list.
$427bn lost annually to tax evasion, reveals report
Tax Justice Network reported that $427bn is stolen annually by companies and individuals who avoid paying taxes and called for the G20 to tighten rules.